Steven L Bernstein1, Polly E Bijur, E John Gallagher. 1. Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA. sbernste@montefiore.org
Abstract
OBJECTIVE: To test whether a single-category improvement on a Likert pain relief scale equals the minimum clinically significant difference of 1.3 units in pain intensity reduction on a 10-unit numerical rating scale (NRS). METHODS: Prospective cohort of adults with acute severe pain receiving standardized analgesia. Patients rated pain intensity via NRS before receiving morphine and 30 minutes later. Patients described pain relief as "none," "a little," "moderate," "a lot," or "complete." The primary outcome was the difference in NRS scores between each contiguous pair of pain relief categories over 30 minutes. RESULTS: One hundred thirty-one patients, age range 21 to 65 years, median baseline NRS pain score 10 (interquartile range, 9-10). Patients whose relief was "complete," "a lot," "moderate," "mild," and "none" had the following NRS unit reductions in pain, respectively: 9, 5.7, 3.9, 2.1, and -0.1. The difference between each pair of relief categories was 3.3, 1.8, 1.8, and 2.2 units. CONCLUSION: Each single-category improvement on a pain relief scale exceeds the minimum clinically significant difference in pain intensity as measured on an NRS.
OBJECTIVE: To test whether a single-category improvement on a Likert pain relief scale equals the minimum clinically significant difference of 1.3 units in pain intensity reduction on a 10-unit numerical rating scale (NRS). METHODS: Prospective cohort of adults with acute severe pain receiving standardized analgesia. Patients rated pain intensity via NRS before receiving morphine and 30 minutes later. Patients described pain relief as "none," "a little," "moderate," "a lot," or "complete." The primary outcome was the difference in NRS scores between each contiguous pair of pain relief categories over 30 minutes. RESULTS: One hundred thirty-one patients, age range 21 to 65 years, median baseline NRS pain score 10 (interquartile range, 9-10). Patients whose relief was "complete," "a lot," "moderate," "mild," and "none" had the following NRS unit reductions in pain, respectively: 9, 5.7, 3.9, 2.1, and -0.1. The difference between each pair of relief categories was 3.3, 1.8, 1.8, and 2.2 units. CONCLUSION: Each single-category improvement on a pain relief scale exceeds the minimum clinically significant difference in pain intensity as measured on an NRS.
Authors: Jeffrey Glassberg; Caterina Minnitti; Caroline Cromwell; Lawrence Cytryn; Thomas Kraus; Gwen S Skloot; Jason T Connor; Adeeb H Rahman; William J Meurer Journal: Am J Hematol Date: 2017-06-05 Impact factor: 10.047
Authors: Neal Hermanowicz; Aaron Ellenbogen; Gordon Irving; Mark Buchfuhrer; Mark J Jaros; Gwendoline Shang; Richard Kim Journal: CNS Drugs Date: 2016-05 Impact factor: 5.749
Authors: Finn Gottrup; Bo Jørgensen; Tonny Karlsmark; R Gary Sibbald; Rytis Rimdeika; Keith Harding; Patricia Price; Vanessa Venning; Peter Vowden; Michael Jünger; Stephan Wortmann; Rita Sulcaite; Gintaris Vilkevicius; Terttu-Liisa Ahokas; Karel Ettler; Monika Arenbergerova Journal: Int Wound J Date: 2007-04 Impact factor: 3.315
Authors: Thierry N Boellaard; Marije P van der Paardt; Susanne Eberl; Markus W Hollmann; Jaap Stoker Journal: BMC Gastroenterol Date: 2011-11-23 Impact factor: 3.067
Authors: Ana C R Pitangui; Rodrigo C Araújo; Michelle J S Bezerra; Camila O Ribeiro; Ana M S Nakano Journal: Braz J Phys Ther Date: 2014 Jan-Feb Impact factor: 3.377
Authors: Aníbal Báez-Suárez; Estela Martín-Castillo; Josué García-Andújar; José Ángel García-Hernández; María P Quintana-Montesdeoca; Juan Francisco Loro-Ferrer Journal: Trials Date: 2018-11-26 Impact factor: 2.279
Authors: Suresh Vedantham; Samuel Z Goldhaber; Jim A Julian; Susan R Kahn; Michael R Jaff; David J Cohen; Elizabeth Magnuson; Mahmood K Razavi; Anthony J Comerota; Heather L Gornik; Timothy P Murphy; Lawrence Lewis; James R Duncan; Patricia Nieters; Mary C Derfler; Marc Filion; Chu-Shu Gu; Stephen Kee; Joseph Schneider; Nael Saad; Morey Blinder; Stephan Moll; David Sacks; Judith Lin; John Rundback; Mark Garcia; Rahul Razdan; Eric VanderWoude; Vasco Marques; Clive Kearon Journal: N Engl J Med Date: 2017-12-07 Impact factor: 176.079